Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Explore the cutting-edge field of chimeric antigen receptor (CAR) cellular immunotherapy in this 43-minute webinar presented by Dr. Qiongsi Zhang, a Senior Product Scientist at Sino Biological with expertise in cancer biology and immunology. Discover how CAR-T cell therapy has revolutionized cancer treatment as a novel therapeutic option, while examining its acknowledged limitations including antigen escape, on-target off-tumor effects, and challenges posed by immunosuppressive microenvironments. Learn about innovative strategies researchers are developing to overcome conventional CAR-T therapy challenges, including dual or tandem CAR expression, CAR structure remodulation, and combination immunotherapies with checkpoint blockade. Investigate the promising alternative of CAR-NK cell therapies, which utilize natural killer cells instead of T cells and offer enhanced safety profiles with reduced risk of negative immune side effects. Examine clinical trial results demonstrating the effectiveness of CAR-NK cell therapies against both solid tumors and hematological malignancies. Understand how comprehensive solutions are being developed to facilitate CAR-T and CAR-NK cell therapy development, covering every stage from initial CAR development through cell preparation and quality control processes. Participate in a live Q&A session to deepen your understanding of this formidable weapon against cancer and its potential to transform oncological treatment approaches.
